NIH researchers identify novel small molecule inhibitors of SARS-CoV-2 variants
A team of scientists from the National Institutes of Health (NIH), USA, has recently identified six novel small molecule inhibitors
Read more
Researchers identify nanobodies that block COVID-19 infection
Australian researchers have identified neutralizing nanobodies that block the SARS-CoV-2 virus from entering cells in preclinical models. The discovery paves
Read more
Study focuses on SARS-CoV-2 antibody seroprevalence in Wuhan and COVID-19 controls
Since the emergence in December 2019 in Wuhan, China, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide via
Read more
Study assess prevalence of SARS-CoV-2 in England after third national lockdown
The alarmingly high infection rate of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the causal agent of the coronavirus 2019
Read more
Researchers develop broad-spectrum SARS-CoV-2 RBD-based vaccine
Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogen. Three emergent SARS-like diseases
Read more
RNA-binding cylinders inhibit SARS-CoV-2 replication in vitro
Research led by Michael J. Hannon from the University of Birmingham, UK, finds metallo-supramolecular helicates (cylinders) binding to untranslated regions
Read more
Are marine mammals are at risk of COVID-19?
As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to circulate around the world, ecologists have become increasingly concerned about
Read more
SARS-CoV-2 inhibits the cellular response to interferon
Severe coronavirus disease 2019 (COVID-19) is associated with the development of acute respiratory distress syndrome (ARDS), characterized by exacerbated inflammation
Read more
Oxford-AstraZeneca vaccine effective against B.1.1.7 SARS-CoV-2 variant
The coronavirus disease (COVID-19) pandemic continues to spread globally, with new variants emerging. One of the severe acute respiratory syndrome
Read more
COVID-19 vaccines reduce virus transmission in healthcare worker case study
The deployed coronavirus disease 2019 (COVID-19) vaccines have been shown to provide robust immune responses for those administered. However, little
Read more